MedTrace Logo

Vasculopathy, Inflammation and Systemic Sclerosis

NCT02562079 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2026-05-14

No results posted yet for this study

Summary

It is a study of basic research with mechanistically objectives and including clinical biological samples.

Conditions

Interventions

BIOLOGICAL

Blood samples

* biological features of the standard follow-up * 2 more blood tube for the biological collection (serum and PBMC)

BIOLOGICAL

Biopsy

Skin biopsies

Sponsors & Collaborators

  • Societe Francaise de Rhumatologie

    collaborator OTHER

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Marie-Elise TRUCHETET, MD · University Hospital Bordeaux, France

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02562079 on ClinicalTrials.gov